Braskem (BAK) updates treasury share and derivatives data in 6-K filing
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Braskem S.A. submitted a Form 6-K as a foreign private issuer, mainly to report its securities and derivatives activity for April in line with Brazilian CVM Instruction # 358/2002 as amended by Instruction # 568/2015, including information on shares held in treasury.
The filing also includes an extensive disclaimer on forward-looking statements, highlighting that comments about strategy, future operations and the impact of the geological event in Alagoas and COVID-19 involve risks, uncertainties and assumptions, and refers readers to Braskem’s Form 20-F and subsequent Exchange Act reports for a fuller discussion of risk factors.
Positive
- None.
Negative
- None.
Key Terms
Form 6-K, foreign private issuer, CVM Instruction # 358/2002, CVM Instruction # 568/2015, +2 more
6 terms
Form 6-K regulatory
"SECURITIES AND EXCHANGE COMMISSION FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
CVM Instruction # 358/2002 regulatory
"INDIVIDUAL FORM SHARES HELD IN TREASURY(Article 11 of CVM Instruction # 358/2002"
CVM Instruction # 568/2015 regulatory
"amended by Article I of CVM Instruction # 568/2015"
forward-looking statements financial
"DISCLAIMER ON FORWARD-LOOKING STATEMENTS This report on Form 6-K may contain forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
geological event in Alagoas financial
"including any potential or projected impact of the geological event in Alagoas and related legal proceedings"
FAQ
What is Braskem S.A. (BAK) reporting in this Form 6-K?
Braskem S.A. uses this Form 6-K to report its April activity in securities and derivatives, complying with Brazilian CVM Instruction # 358/2002 as amended. It also provides information on shares held in treasury and includes a detailed forward-looking statements disclaimer for investors.
Why does Braskem S.A. (BAK) include a forward-looking statements disclaimer?
Braskem includes a forward-looking statements disclaimer to caution that expectations about operations, strategies and financial results involve risks and uncertainties. It emphasizes assumptions about economic conditions, industry factors, the Alagoas geological event and COVID-19, which may cause actual results to differ materially from management’s current views.
Which SEC annual report form does Braskem S.A. (BAK) use?
Braskem confirms it files its annual reports with the SEC on Form 20-F. The 6-K explicitly references the Form 20-F for the year ended December 31, 2019 and later filings as primary sources for detailed risk discussions and additional information for investors and stakeholders.
Who signed Braskem S.A.’s May 2026 Form 6-K and in what role?
The Form 6-K is signed on behalf of Braskem S.A. by Felipe Montoro Jens, acting as Chief Financial Officer. The signature confirms that the report was duly authorized under the requirements of the Securities Exchange Act of 1934 for foreign private issuers furnishing information to the SEC.
